Proposed Federal Use of March-in Rights Would Weaken American Innovation
December 22, 2023
By Sujai Shivakumar and Thomas Howell The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of